Your location：Home >News center >Industry News
Industry News
08-282021
Antibody-Drug Conjugates for Cancer Thera…
Antibody-drug conjugates (ADCs) are a rapidly evolving class of anticancer therapeutics consisting of antibodies attached to potent cytotoxic drugs via chemical linkers.
05-112021
CDK4/6 Inhibitors for Treatment of Advanc…
There are three CDK4/6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib approved by FDA to treat Advanced Breast Cancer.
sales@huatengusa.com
+86 0731 89916275